NeuroSense Therapeutics Israeli Company
NeuroSense Therapeutics is a drug development company offering a treatment for patients with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The companys drug, PrimeC, is a unique formulation combining two FDA-approved compounds for unrelated conditions.
Health Tech & Life Sciences
Biotechnology
Neuroscience
Therapeutics
Alternatives
No alternatives listed yet.
Suggest an Alternative
Founders
Parent Companies/Investors
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/neurosense-therapeutics
[2]
crunchbase.com
- https://www.crunchbase.com/organization/neurosense-therapeutics
External links are provided for reference and verification purposes.